Cardax, Inc.
Cardax, Inc. (CDXI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CDXI · as of Jun 9, 2026
Key Statistics
Explore Cardax, Inc. Data
cdxi stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cdxi competitorsCDXI
ELOX
LGBI
MDVLQ
MICRD
MODCStock Performance
Full HistoryAbout Cardax, Inc.
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments f…
what is cardax, inc. · cdxi stock overview · cardax, inc. company profile · who is cardax, inc. ceo · cdxi OTC · cardax, inc. headquarters · cardax, inc. business segments
About Stock Overview & Key Data
Cardax, Inc. (CDXI) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 6, 2013. As of the latest trading session, CDXI stock price is $0.00, with a market capitalization of $80. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Cardax, Inc. reported revenue of $538946.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cardax, Inc. (CDXI) stock price is $0.00. The stock is traded on OTC under the ticker symbol CDXI. The 52-week range is $0.00 – $0.00.